CapsoVision, Inc. (CV) NASDAQ
6.46
+0.21(+3.36%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
6.46
+0.21(+3.36%)
Currency In USD
| Previous Close | 6.25 |
| Open | 6.25 |
| Day High | 6.58 |
| Day Low | 6.22 |
| 52-Week High | 15.37 |
| 52-Week Low | 3.43 |
| Volume | 89,634 |
| Average Volume | 374,713 |
| Market Cap | 321.95M |
| PE | -6.04 |
| EPS | -1.07 |
| Moving Average 50 Days | 5.76 |
| Moving Average 200 Days | 5.71 |
| Change | 0.21 |
CapsoVision to Participate in the 38th Annual ROTH Conference
GlobeNewswire Inc.
Mar 09, 2026 8:05 PM GMT
- Company to participate in a fireside chat and 1x1 investor meetings on March 23, 2026 - SARATOGA, Calif., March 09, 2026 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-stage medical technology company developing advanced imaging
CapsoVision Announces 510(k) Submission for the Addition of AI-Assisted Reading Module in CapsoCam Plus®
GlobeNewswire Inc.
Dec 29, 2025 9:05 PM GMT
Company Preparing to Commence Commercialization Following U.S. FDA 510(k) ClearanceSARATOGA, Calif., Dec. 29, 2025 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-stage medical technology company developing advanced imaging and AI-
CapsoVision to Participate in the Benchmark 14th Annual Discovery Investor Conference
GlobeNewswire Inc.
Nov 20, 2025 9:05 PM GMT
Company to participate in 1:1 Investor Meetings on December 4, 2025SARATOGA, Calif., Nov. 20, 2025 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-stage medical technology company developing advanced imaging and AI-enabled capsule